What You Should Know:
– Millions of Americans with Type 2 diabetes and prediabetes now have a new option for managing their glucose levels.
– DexCom, a leader in continuous glucose monitoring (CGM) technology announced the launch of Stelo, the first over-the-counter (OTC) glucose biosensor available in the US.
What is Stelo?
Stelo is a small, wearable sensor that provides real-time glucose readings directly to a smartphone app. Unlike traditional blood glucose meters, Stelo offers continuous monitoring, eliminating the need for painful fingersticks. This allows users to gain valuable insights into how food, exercise, and sleep affect their glucose levels, empowering them to make informed lifestyle choices.
Key Benefits of Stelo:
- No Fingersticks: Stelo is the only OTC glucose biosensor that eliminates the need for finger pricking.
- Long Wear Time & Waterproof: Stelo boasts the longest wear time (up to 15 days) and the highest waterproof rating among OTC biosensors.
- Personalized App: The accompanying app provides daily, weekly, and session summaries, helping users develop healthier habits.
- Spike & Pattern Detection: Stelo is the only OTC option offering spike detection, allowing users to identify significant glucose fluctuations.
- Proven Results: DexCom’s sensor technology, used in Stelo, has been shown to lower A1c and improve quality of life for people with Type 2 diabetes.
Who is Stelo For?
Stelo is ideal for adults with Type 2 diabetes who are not using insulin, as well as individuals with prediabetes seeking to optimize their health and manage their glucose levels.
Ordering and Pricing:
Stelo is available for purchase directly through Stelo.com and is compatible with Flexible Spending Accounts (FSA) and Health Savings Accounts (HSA). Two pricing options are available:
- Pay-as-you-go: $99 for a single pack of two sensors (total wear time up to 30 days).
- Monthly subscription: $89 per month for ongoing delivery of two sensors (total wear time up to 30 days).
“Dexcom has been at the forefront of glucose biosensing for 25 years. With the launch of Stelo, we’re defining a brand-new category and once again setting the gold standard for people to easily take control of their health,” said Jake Leach, executive vice president and chief operating officer at Dexcom. “Now, millions more have access to 24/7, easy-to-understand glucose insights that can inform their daily lifestyle choices and support behavior modification.”
